[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) NOTICE OF 2019 ANNUAL GENERAL MEETING NOTICE IS HEREBY GIVEN Company RESOLUTIONS WITHOUT THE ADOPTION OF CUMULATIVE VOTING SYSTEM: ORDINARY RESOLUTIONS 1. THAT Directors Director Board 2. THAT Supervis]
[CONTENTS] [SPECIMEN * NOT VALID UNLESS COUNTERSIGNED BY TRANSFER AGENT * INCORPORATED UNDER THE LAWS OF THE GOVERNMENT OF ANTIGUA Number Sinovac Shares BIOTECH LTD. This Certifies that Is the Owner of Fully paid and non-assessable shares of Common Stock of Sinovac Biotech Ltd. transferable on the bo]
[Number 99.1 Notice of 2019 Annual General Meeting. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Wu Haijun Chairman of the Board of Directors]
[] [Ordinary Shares Type and Class of Securities (Item 9.A.5 of Form 20-F) Preemptive Rights (Item 9.A.3 of Form 20-F) The holders of the Company’s ordinary shares do not have preemptive right. Limitations or Qualifications (Item 9.A.6 of Form 20-F) See “General,” “Voting Rights,” “Conversion of the ]
[Number 99.1 Notice of 2019 Annual General Meeting. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Wu Haijun Chairman of the Board of Directors]
[] [Ordinary Shares Type and Class of Securities (Item 9.A.5 of Form 20-F) Preemptive Rights (Item 9.A.3 of Form 20-F) The holders of the Company’s ordinary shares do not have preemptive right. Limitations or Qualifications (Item 9.A.6 of Form 20-F) See “General,” “Voting Rights,” “Conversion of the ]
[None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report. As of December 31, 2019, 40,858,290 shares of common stock, par value US$0.10 per share, and on]
